Cargando…
The development of a novel antioxidant-based antiemetic drug to improve quality of life during anticancer therapy
Anticancer agents can effectively treat several types of cancers but are often limited in clinical settings due to various adverse effects. In particular, nausea and vomiting are serious side effects that markedly reduce the patients' quality of life. Accordingly, the development of novel antie...
Autores principales: | Yanagawa, Hiroto, Koyama, Yoshihisa, Kobayashi, Yuki, Kobayashi, Hikaru, Shimada, Shoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552029/ https://www.ncbi.nlm.nih.gov/pubmed/36237446 http://dx.doi.org/10.1016/j.bbrep.2022.101363 |
Ejemplares similares
-
Therapeutic strategy for facial paralysis based on the combined application of Si-based agent and methylcobalamin
por: Koyama, Yoshihisa, et al.
Publicado: (2022) -
Diverse Possibilities of Si-Based Agent, a Unique New Antioxidant
por: Koyama, Yoshihisa, et al.
Publicado: (2023) -
Effect of the new silicon-based agent on the symptoms of interstitial pneumonitis
por: Shimada, Masato, et al.
Publicado: (2023) -
A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent
por: Koyama, Yoshihisa, et al.
Publicado: (2022) -
Author Correction: A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent
por: Koyama, Yoshihisa, et al.
Publicado: (2022)